Facts
- Product: A microchip for growing and supplying human cells with oxygen / nutrients
- Sector: Life Sciences & Health
- Founded: 2017
- Amount invested: € 250.000
- Status: Active
Facts
Bi/OND
Bi/ond a spin-off from TU Delft, founded in 2017, has developed a computer chip and platform on which biologists place the cells of an individual.
Everyone is different from everyone else in unique ways, but current medical treatments do not match genetic variation between individuals. People of different backgrounds, genders and ages are given drugs that are developed based on genetic criteria that are very different from their own genetic material.
In addition, current drug research methods force biologists to choose between two options: animal testing or culturing cells under laboratory conditions (in vitro). Neither method takes sufficient account of the diversity between individuals. They do not sufficiently predict what will happen in the human body, because the environment in which the cells are examined is little like it. Bi/ond technology offers a solution to this problem.
Ludolf Stavenga
Investment Manager
(TU Delft)
